Personalized genomics
- Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers
Editors' choice: Personalized therapeutic targets for triple-negative breast cancers remain an important unmet clinical need. Genomic profiling of murine Trp53-null tumors identified a number of promising drug targets conserved in humans.